In the new crown epidemic prevention and control, the name of Lianhua Qingwen should be familiar to everyone. It has been recommended by the country and more than 20 provinces and cities in the new coronavirus pneumonia diagnosis and treatment plan, and has become one of the most frequently recommended Chinese patent medicines. It is worth mentioning that following Lianhua Qingwen, its sister drug Lianhua Qingwen has also become a recommended drug in many provinces and cities’ traditional Chinese medicine treatment plans for COVID-19.
Recently, in the "Guidelines for Home-based Traditional Chinese Medicine Intervention for People Infected with COVID-19" issued by the National Administration of Traditional Chinese Medicine, both drugs were listed as recommended drugs. Why are the two recommended? Can they be used together to enhance the efficacy? What should be paid attention to when using them?
Drawing on the millennium experience of traditional Chinese medicine in treating epidemics, the formulas have different emphasis
Lianhua Qingke and Lianhua Qingwen have the same roots and teachers, and they are both derived from the guidance of "lung syndrome treatment" in the theory of collateral disease in traditional Chinese medicine. The reason why the two have come to the fore many times in epidemic prevention and control work is precisely because of the advantages of their combination.
Lianhua Qingwen's prescription draws on the 2000 years of experience in preventing and treating plague with traditional Chinese medicine, and integrates the essence of medicines used by famous doctors from three dynasties to treat epidemic diseases. Shigan Decoction is combined with Yinqiao Powder, which is specially used to treat epidemic diseases in Wu Jutong's Treatise on Warm Epidemics in the Qing Dynasty. It draws on the experience of using rhubarb in treating epidemic syndromes in Wu Youke's Treatise on Warm Epidemics in the Ming Dynasty, so that poisonous and heaty evils can be expelled from the stool.
Modern pharmacological research has found that Lianhua Qingwen has good antipyretic, cough-relieving, anti-inflammatory and anti-viral effects. It can clear away heat and detoxify the lungs and relieve heat. It can treat the symptoms of fever and muscle aches in patients with influenza. It also has a certain therapeutic effect on nasal congestion, runny nose, cough, pain and sore throat.
Lianhua Qingke also draws on thousands of years of experience in treating epidemics with traditional Chinese medicine. It integrates the Maxing Shigan Decoction that has the effect of clearing the lungs and releasing heat in Zhang Zhongjing's "Treatise on Febrile and Miscellaneous Diseases" of the Eastern Han Dynasty and the Qingjin Huatan Decoction that has the effect of clearing the lungs, relieving cough and reducing phlegm.
provides symptomatic treatment and protects healthy respiratory tract, and can be used separately or synergistically.
In addition to the advantages of their formulations, the medical research results of these two drugs have also received international attention and recognition. For example, the international journal "Evidence-Based Complementary and Alternative Medicine" published a real-world research paper on " Lianhua Qingwen Capsules Preventing New Coronavirus Pneumonia ". The paper shows that Lianhua Qingwen Capsules can effectively treat influenza and COVID-19, while increasing the symptom disappearance rate of confirmed patients by 91.5%, shortening the duration of fever and fatigue symptoms by 3 days, and increasing the clinical cure rate by 12%.
The clinical study of Lianhua Qingke Tablets in the treatment of COVID-19 showed that its clinical remission rate in treating COVID-19 reached 98.61%, improved the disappearance rate of cough symptoms by 16.5%, increased the disappearance rate of sputum symptoms by 21.4%, shortened the recovery time of cough and sputum symptoms by 3 days, and increased the clinical cure rate by 22.4%. Based on definite evidence and effects, Lianhua Qingke Tablets has become a recommended drug in the traditional Chinese medicine diagnosis and treatment plan for new coronavirus pneumonia in Beijing, Shandong, Hubei, Hebei, Sichuan, Fujian and other provinces (cities).
Lianhua Qingke is a sister drug of Lianhua Qingwen capsules/granules. The former focuses on relieving cough and reducing phlegm, and improving the symptoms of cough and sputum in patients with new coronavirus pneumonia; the latter focuses on "clearing plague and detoxifying", focusing on anti- virus , anti-inflammatory, reducing fever and improving fatigue and other systemic discomforts. The combined use of the two has a better effect and can improve a variety of new coronavirus symptoms.
Through the above introduction, I believe everyone has a better understanding of Lianhua Qingke and Lianhua Qingwen. Finally, I would like to remind everyone that when taking medicine, try to take it according to the doctor's advice, prescription or instructions.
comes from: Shanxi Evening News
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-